Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q46859004)
Watch
English
CETP inhibition
scientific article published in December 2007
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18068495
retrieved
25 December 2017
reference URL
http://europepmc.org/abstract/MED/18068495
title
CETP inhibition
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18068495
retrieved
25 December 2017
reference URL
http://europepmc.org/abstract/MED/18068495
author name string
Patrick Duriez
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18068495
retrieved
25 December 2017
reference URL
http://europepmc.org/abstract/MED/18068495
language of work or name
English
0 references
publication date
1 December 2007
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18068495
retrieved
25 December 2017
reference URL
http://europepmc.org/abstract/MED/18068495
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18068495
retrieved
25 December 2017
reference URL
http://europepmc.org/abstract/MED/18068495
volume
370
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18068495
retrieved
25 December 2017
reference URL
http://europepmc.org/abstract/MED/18068495
issue
9603
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18068495
retrieved
25 December 2017
reference URL
http://europepmc.org/abstract/MED/18068495
page(s)
1882-1883
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18068495
retrieved
25 December 2017
reference URL
http://europepmc.org/abstract/MED/18068495
cites work
Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961788-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of torcetrapib in patients at high risk for coronary events
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961788-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961788-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961788-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of torcetrapib on the progression of coronary atherosclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961788-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961788-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961788-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-density lipoprotein as a therapeutic target: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961788-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961788-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961788-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(07)61788-7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18068495
retrieved
25 December 2017
reference URL
http://europepmc.org/abstract/MED/18068495
PubMed publication ID
18068495
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18068495
retrieved
25 December 2017
reference URL
http://europepmc.org/abstract/MED/18068495
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit